Dr. Julie Gerberding doesn’t want you to miss a dose: she ran CDC, now she is president of Merck Vaccines
Similar Posts
“The nasal spray version of the flu vaccine did not protect young children against swine flu last year and might not this year”/AP
From the Associated Press: The nasal spray version of the flu vaccine did not protect young children against swine flu last winter and might not work again this year, health officials said Thursday. Preliminary results from three studies found that AstraZeneca’s FluMist had little or no effect in children against swine flu. That was the…
Doctors don’t understand how to use the drug USG paid $Billions for, so now pharmacists will be prescribing it. How much evidence do you need that the federal health agencies are not out for good? They really want to get the trashy drugs into us.
Doctors are clamoring for more clarity on Paxlovid prescribing amid Covid-19 rebound concerns https://www.statnews.com/2022/07/07/paxlovid-prescribing-covid19-rebounds-data/ By Edward ChenJuly 7, 2022 Reprints + A patient with pills of Paxlovid. Six months after the emergency use authorization of Paxlovid for high-risk Covid patients, physicians say prescribing still isn’t clear-cut.ALEX WELSH/THE NEW YORK TIMES Six months after regulators issued an emergency…
Frequent Boosters Spur Warning on Immune Response/ Bloomberg. Bad news and good news
I knew bad news on the vaccines was going to break soon, given the admissions by Pfizer and BioNTech CEOs that their vaccines didn’t work, and they were not encouraging on the booster doses either. Below is the bad news for boosters. Hopefully the kill shot. The good news is that antivirals work against COVID,…
This is federal LAW for use of EUA products. Most of it is not being adhered to. You don’t have to go along if your boss breaks the law.
https://www.law.cornell.edu/uscode/text/21/360bbb-3 21 U.S. Code § 360bbb–3 – Authorization for medical products for use in emergencies (A)Required conditions With respect to the emergency use of an unapproved product, the Secretary, to the extent practicable given the applicable circumstances described in subsection (b)(1), shall, for a person who carries out any activity for which the authorization is issued, establish such conditions on an authorization…
Reforms Seen Failing to Rescue U.S. Biodefense Drug Efforts/ GSN
From the NY Times, adapted by Global Security Newswire: … The nation’s preparations for a biological strike face numerous challenges, according to more than 100 interviews with high-level officials at participating federal entities such the National Institutes of Health and the White House, as well as the the Health and Human Services, Defense and Homeland…
FDA authorizes first rapid ‘point-of-care’ test for coronavirus/ WaPo
“The Food and Drug Administration late Friday approved the first coronavirus test that can be conducted entirely at the point of care for a patient — and deliver results in 45 minutes. The FDA granted “emergency use authorization” to Cepheid, a California company that makes a rapid molecular test for the coronavirus. The turnaround time for Cepheid’s…